Amphetamine-Induced Place Preference in Humans

Biological Psychiatry

Volumn 65, Issue 10, 2009, Pages 900-904

  Childs, Emma ^a   de Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamine; conditioned place preference; human; subjective effects

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DYSPHORIA; ENVIRONMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; PLACE PREFERENCE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM;

ADULT; AFFECT; ANXIETY; CHOICE BEHAVIOR; CONDITIONING (PSYCHOLOGY); DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; ENVIRONMENT; FEMALE; HUMANS; MALE; PLACEBOS;

EID: 65049091060     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.11.016     Document Type: Article

References (33)

1. van der Kooy D. Place conditioning: A simple and effective method for assessing the motivational properties of drugs. In: Bozarth M.A. (Ed). Methods of Assessing the Reinforcing Properties of Abused Drugs (1987), Springer-Verlag, New York 229-240
2. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56 (1998) 613-672
3. Bozarth M.A. Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacol Biochem Behav 35 (1990) 485-487
4. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98 (1989) 357-362
5. Hoffman D.C. The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23 (1989) 373-387
6. van der Kooy D., Mucha R.F., O'Shaughnessy M., and Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res 243 (1982) 107-117
7. Carr G.D., Fibiger H.C., and Phillips A.G. Conditioned place preference as a measure of drug reward. In: Liebman J.M., and Cooper S.J. (Eds). The Neuropharmacological Basis of Reward (2006), Clarendon Press, Oxford 264-319
8. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict Biol 12 (2007) 227-462
9. Bardo M.T., and Bevins R.A. Conditioned place preference: What does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 153 (2000) 31-43
10. Chutuape M.A., and de Wit H. Relationship between subjective effects and drug preferences: Ethanol and diazepam. Drug Alcohol Depend 34 (1994) 243-251
11. de Wit H., and Griffiths R.R. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 28 (1991) 83-111
12. de Wit H, Phan L (in press): Positive reinforcement theories of drug use. In: Kassel JD, editor. Substance Abuse and Emotion. Washington, DC: American Psychological Association.
13. de Wit H., Uhlenhuth E.H., and Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16 (1986) 341-360
14. Fischman M.W., and Foltin R.W. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86 (1991) 1563-1570
15. Johanson C.E., and Uhlenhuth E.H. Drug preferences in humans. Fed Proc 41 (1982) 228-233
16. Lamb R.J., Preston K.L., Schindler C.W., Meisch R.A., Davis F., Katz J.L., et al. The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. J Pharmacol Exp Ther 259 (1991) 1165-1173
17. Spyraki C., Fibiger H.C., and Phillips A.G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253 (1982) 185-193
18. American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatry. 4th ed. (1994), American Psychiatric Association, Washington, DC
19. McNair D., Lorr M., and Droppleman L. Profile of Mood States (1971), Eduational and Industrial Testing Service, San Diego, CA
20. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12 (1971) 245-258
21. Johanson C.E., and Uhlenhuth E.H. Drug preference and mood in humans: Diazepam. Psychopharmacology 71 (1980) 269-273
22. Cunningham C.L., Ferree N.K., and Howard M.A. Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology (Berl) 170 (2003) 409-422
23. Cunningham C.L., Gremel C.M., and Groblewski P.A. Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1 (2006) 1662-1670
24. Nomikos G.G., and Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl) 94 (1988) 119-125
25. Cervo L., Rossi C., and Samanin R. Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus. Eur J Pharmacol 238 (1993) 201-207
26. Schechter M.D. Cocaethylene produces conditioned place preference in rats. Pharmacol Biochem Behav 51 (1995) 549-552
27. Schenk S., Ellison F., Hunt T., and Amit Z. An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats. Pharmacol Biochem Behav 22 (1985) 215-220
28. Brielmaier J.M., McDonald C.G., and Smith R.F. Nicotine place preference in a biased conditioned place preference design. Pharmacol Biochem Behav 89 (2008) 94-100
29. Evans S.M., Griffiths R.R., and de Wit H. Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology (Berl) 123 (1996) 154-163
30. Roache J.D., Meisch R.A., Henningfield J.E., Jaffe J.H., Klein S., and Sampson A. Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures. Pharmacol Biochem Behav 50 (1995) 171-179
31. Dlugos A., Freitag C., Hohoff C., McDonald J., Cook E.H., Deckert J., et al. Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry 61 (2007) 1296-1305
32. Gabbay F.H. Variations in affect following amphetamine and placebo: Markers of stimulant drug preference. Exp Clin Psychopharmacol 11 (2003) 91-101
33. Lott D.C., Kim S.J., Cook Jr. E.H., and de Wit H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30 (2005) 602-609